| 2023-05-22 | Sale | Omeros Corporation OMER | director | 5,000 0.008% | $6.46 | $32,300 | -45.85% | |
| 2022-06-03 | Salarius Pharmaceuticals, Inc. SLRX | 28,000 0.0521% | $0.18 | $5,152 | -52.08% | |||
| 2021-08-10 | Salarius Pharmaceuticals, Inc. SLRX | director | 7,000 0.0156% | $0.88 | $6,167 | -48.23% | ||
| 2020-08-21 | Salarius Pharmaceuticals, Inc. SLRX | director | 4,000 0.0226% | $0.98 | $3,920 | +10.72% | ||
| 2020-02-11 | Salarius Pharmaceuticals, Inc. SLRX | director | 4,350 0.0628% | $1.15 | $5,003 | +6.95% | ||
| 2019-11-25 | Salarius Pharmaceuticals, Inc. SLRX | director | 6,000 0.1664% | $3.59 | $21,540 | -73.79% | ||
| 2013-01-03 | Omeros Corporation OMER | director | 2,000 0.0078% | $5.58 | $11,160 | +0.81% | ||
| 2012-05-18 | Sale | Eli Lilly and Company LLY | Chief Accounting Officer | 1,295 0.0001% | $40.49 | $52,435 | +23.72% | |
| 2011-05-17 | Sale | Eli Lilly and Company LLY | Chief Accounting Officer | 3,378 0.0003% | $39.12 | $132,147 | -1.07% | |
| 2009-11-20 | Sale | Eli Lilly and Company LLY | Chief Accounting Officer | 2,673 0.0002% | $36.65 | $97,965 | -1.3% | |
| 2007-05-02 | Sale | Eli Lilly and Company LLY | Chief Accounting Officer | 1,565 0.0001% | $59.39 | $92,945 | -5.94% | |
| 2006-09-18 | Sale | Eli Lilly and Company LLY | Chief Accounting Officer | 1,250 <0.0001% | $34.59 | $43,244 | +2.97% | |
| 2005-09-15 | Sale | Eli Lilly and Company LLY | Chief Accounting Officer | 2,864 0.0001% | $23.41 | $67,039 | +1.94% |